Snake venom peptide powder

• Customization: Available
• CAS No.: 823202-99-9
• Formula: C2H4O2
• Storage Method: Normal
• Shelf Life: 24 Months
• Nutrient Composition: Mineral
• Resource: Natural
• The content of active substances: 100%
• Transport Package: 25 Kg/Carton Outside and Double Food Plastic Bags
• Specification: 98%
• Trademark: SOST
• Origin: China
• Production Capacity: 100 Kg/Momth

Product Description

Product Description

Snake venom peptides are substances secreted by the snake glands of vipers, which have pharmacological effects such as analgesia, hemostasis, inhibition of thrombosis and antitumor, and have been made into some snake venom preparations for clinical application. However, because snake venom peptides are the most complex type of animal venom, there are at least 20 kinds of active components in each kind of snake venom, including various toxins, enzymes and active peptides, and most of the active components may cause serious toxic side effects in the body, such as cardiotoxicity, neurotoxicity, etc. These toxic side effects are the main reason to limit the application of snake venom preparations in clinical treatment. These toxic side effects are the main reasons limiting the application of snake venom preparations in clinical treatment.

1.Anti cancer
Erpentine peptides show interesting anticancer activity and selectivity, with desintegrins, PLA2 and LAOOs exhibiting a primitive mode of action compared to membrane-disrupting peptides. However, as demonstrated by the premature discontinuation of the phase I clinical trial of VRCTC-310, the size of these peptides makes them susceptible to immune responses. In addition, the low bioavailability of the peptides limits their systemic administration. In the future, studies focused on combining snake venom peptides with complex nanoparticle systems will be more likely to yield drug precursors with selective and controlled delivery.

2.Hemostatic
Snake venom peptides have good analgesic and hemostatic effects, and are good for inhibiting thrombosis. Previously, snake venom components also have better anti-inflammatory effects, thus achieving analgesic and hemostatic effects, and snake venom peptides can regulate cell proliferation and apoptosis, which are combined and usually used in medical treatment to inhibit thrombosis

 

1.Clinical
Peptides and small proteins play different roles in numerous physiological processes and exert a wide range of pharmacological activities, such as antibacterial, antihypertensive, analgesic, antitumor, and analgesic.
Peptides from snake venom have had a major impact on the field of thrombosis and hemostasis due to their pro- and anti-coagulant activities.

2.Anti-hypertensive
The antihypertensive drug captopril, the first drug based on the bioactive component of snake venom, was approved by the FDA in 1981 in the United States and in 1984 in European countries.

 

Certificate of Analysis

Product Name	Dipeptide Diaminobutyroyl Benzylamide Diacetate
CAS No.	823202-99-9	Batch No.	2022050701
Molecular Formula	C19H29N5O:(CH4O2)2	Molecular Weight	495.57
Date of Producing	2022/05/07	Expiry Date	2024/05/06
Date of Survey	2022/05/13	Condition of Storage	2~8ºC
Reference Standard	Enterprise Standard

 

TEST	SPECIFICATION	RESULT
Appearance	White or almost white crystals or powder	Conform
Solubility	Soluble in water	Conform
Water Content  (Karl Fischer)	≤8.0%	5.6%
PH	5.0~8.0	6.5
Peptide Purity	>95.0%	99.1% ( HPLC)
Conclusion	the product conforms with enterprise standard,and qualified

You May Like